Aquestive Therapeutics, Inc. Common Stock

Go to Aquestive Therapeutics, Inc. Common Stock Website

$3.92

-0.10 (-2.61%)
Live
Previous Close

$4.02

Day Range

$3.875 - $4.065

Previous Day Range

$3.83 - $4.04

Market Cap

$379.4 million USD

Day Vol.

484766

Previous Day Vol.

508638

Currency

USD

Primary Exchange

Nasdaq

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Aquestive Therapeutics announced the promotion of Sherry Korczynski to Chief Commercial Officer, focusing on driving the commercial strategy for Anaphylm, a breakthrough oral epinephrine delivery product for anaphylaxis treatment.

Related tickers: AQST, LLY.

Read Full Article

Aquestive Therapeutics announced positive pharmacokinetic results from a pediatric study for its Anaphylm product and completed the submission of its New Drug Application to the FDA.

Related tickers: AQST.

Read Full Article
Trending Tickers

Please sign in to view